Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Hideki FujiiNamiki Izumi

Abstract

To evaluate the virologic responses and clinical course of daclatasvir plus asunaprevir treatment in non-hemodialysis (non-HD) and hemodialysis (HD) patients infected with genotype 1 hepatitis C virus (HCV). A total of 1113 non-HD patients and 67 HD patients were assessed. To evaluate pretreatment factors contributing to sustained virological response at 12 weeks (SVR12), univariate and multivariate analyses were carried out. To adjust for differences in patient background, propensity score matching was undertaken. The overall SVR12 rates were 91.6% in non-HD patients and 95.5% in HD patients. Compared with non-HD patients, HD patients were younger, were more likely to be male, were less likely to have received interferon-based pretreatment, had a lower viral load, and had lower levels of alanine transaminase, hemoglobin, and α-fetoprotein. Multivariate analysis revealed that viral load, α-fetoprotein, L31 substitution negative, and Y93 substitution negative were independent predictive factors for SVR12 in non-HD patients. The proportion of patients with undetectable HCV-RNA during the initial 4 weeks was significantly higher in HD patients than in non-HD patients. The SVR12 rate was clearly higher in HD patients than in non-HD...Continue Reading

References

Oct 31, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F FabriziF Locatelli
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anaïs Vallet-PichardStanislas Pol
Dec 17, 2009·Gastroenterology·Christoph Sarrazin, Stefan Zeuzem
Apr 17, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Izumi NamikiMasatoshi Kudo
Aug 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert A FridellMin Gao
Oct 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kazuaki ChayamaHiromitsu Kumada
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Jun 12, 2013·Nature Reviews. Microbiology·Ralf BartenschlagerFrancois Penin
Mar 8, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hiromitsu KumadaEric Hughes
Mar 19, 2014·Gastroenterology·Jean-Michel Pawlotsky
Jul 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jane P MessinaEleanor Barnes
Aug 15, 2014·JAMA : the Journal of the American Medical Association·Anita KohliShyam Kottilil
Sep 10, 2014·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Kan KikuchiTadao Akizawa
Jan 17, 2015·World Journal of Gastroenterology : WJG·Roberto J Carvalho-FilhoMaria Lucia G Ferraz
Feb 7, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Muneshige ShiraishiYoshihide Nogami
May 5, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Eiichi OgawaUNKNOWN Kyushu University Liver Disease Study(KULDS) Group
Jan 21, 2017·World Journal of Hepatology·Toshikuni SudaMasaya Tamano
Feb 9, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlos Fernández CarrilloJosé Luis Calleja

❮ Previous
Next ❯

Citations

Mar 2, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ahmad AyadiAbolfazl Fateh
Jun 19, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Atsunori KusakabeNamiki Izumi
Mar 12, 2021·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Masanori AtsukawaKatsuhiko Iwakiri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.